Zobrazeno 1 - 9
of 9
pro vyhledávání: '"I. V. Buravtsova"'
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 36-38 (2022)
Clinical efficiency of Dacogen (inhibitor of DNA hypermethylation) in 16 patients with MDS is presented. Bone marrow cytogenetic studies were performed in 6 patients; the detected chromosome aberrations included 5q deletion in 1 patient, X monosomy i
Externí odkaz:
https://doaj.org/article/97419dbb66be459c8485286dab601154
Autor:
T. D. Lutskaya, A. K. Golenkov, T. A. Mitina, I. V. Buravtsova, G. A. Dudina, L. L. Vysotskaya, E. V. Trifonova, E. V. Kataeva, O. V. Moskalets, V. V. Yazdovskiy
Publikováno v:
Онкогематология, Vol 6, Iss 3, Pp 18-23 (2014)
This study aimed to evaluate treatment results in patients with diffuse large cell lymphoma (DBL CL) received R-CHOP program (as 1 st and2 nd line therapy), including cases with complications. We observed 77 DBLCL patients (50 primary and 27 received
Externí odkaz:
https://doaj.org/article/95c222969ff8490a9bf0f1bd66624731
Autor:
A. K. Golenkov, L. L. Vysotskaya, E. V. Trifonova, T. A. Mitina, T. D. Lutskaya, E. V. Kataeva, G. A. Dudina, Yu. B. Chernykh, I. V. Buravtsova, A. N. Gurov, R. V. Gorenkov
Publikováno v:
Онкогематология, Vol 7, Iss 3, Pp 17-21 (2014)
Imatinib (IM) treatment efficacy in 116 chronic myeloid leukemia (CML) patients in different studies was analyzed. Patient group was non‑selective with prospective enrollment. The study was based on real‑time patient’s register allows to treatm
Externí odkaz:
https://doaj.org/article/b12007d41aaf428796f5a4e5b83dd3eb
Autor:
E. V. Kataeva, A. K. Golenkov, E. V. Trifonova, G. A. Dudina, T. A. Mitina, L. L. Vysotskaya, T. D. Lutskaya, I. V. Buravtsova, R. V. Gorenkov, Yu. Yu. Chuksina, V. V. Yazdovskiy
Publikováno v:
Онкогематология, Vol 6, Iss 2, Pp 4-7 (2014)
In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.
Externí odkaz:
https://doaj.org/article/4893c4a74e15490f88df76726c28246f
Publikováno v:
Bulletin of Experimental Biology and Medicine. 164:90-94
The expression of retinoic acid nuclear receptor gene RARα and its relationship with expression of APE1, YB-1, and MDR1 genes was studied in bone marrow aspiration biopsy specimens from 22 patients with newly detected multiple myeloma. The expressio
Publikováno v:
Voprosy onkologii. 62(5)
The significance of quantitative changes of ALDH1A1 and RDH10 gene expression in 22 non-treated multiple myeloma patients were studied. We found a direct correlation between the expression of ALDH1A1 and RDH10 genes. We showed that ALDHA1 and RDH10 e
Autor:
N N, Kalitin, I V, Buravtsova
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 61(8)
The RARa is a transcription factor playing important role in such processes as proliferation, differentiation and apoptosis of cells in norm and in tumor. At the same time, it is little known about significance of expression of two major products of
Autor:
A K Golenkov, I V Buravtsova, G A Dudina, T D Lutskaia, T A Mitina, E V Kataeva, A F Karamysheva, E S Kakpakova, Iu A Sablina, A A Stavrovskaia
Publikováno v:
Терапевтический архив, Vol 85, Iss 7, Pp 98-102 (2013)
AIM: To determine the significance of the angiogenic activity estimated from the gene expression of the vascular endothelial growth factors (VEGFs) VEGF-A, VEGF-C, and VEGF-D and their receptors VEGFR1, VEGFR1s, VEGFR2, and VEGFR3 in the mononuclear
Autor:
N N, Kalitin, I V, Buravtsova
Publikováno v:
Voprosy onkologii. 61(6)
In this study, for the first time the expression of β₂ and β₄ isoforms of RARβ gene was investigated in group of 19 patients with the newly diagnosed multiple myeloma. The expression of both RARβ₂ and RARβ₄ isoforms was detected in all p